China Pharma Holdings, Inc. (CPHI)

Market Cap	5.55M
Revenue (ttm)	4.30M
Net Income (ttm)	-4.57M
Shares Out	3.26M
EPS (ttm)	-2.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	381,840
Open	1.820
Previous Close	1.890
Day's Range	1.650 - 1.880
52-Week Range	1.200 - 3.350
Beta	0.79
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2025

About CPHI

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, cor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Zhilin Li
• Employees: 224
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: CPHI
• Website: https://www.chinapharmaholdings.com

Financial Performance

In 2024, China Pharma Holdings's revenue was $4.53 million, a decrease of -35.41% compared to the previous year's $7.01 million. Losses were -$4.74 million, 53.8% more than in 2023.